the Holy See, "excommunication for those who use it and for those who require"
RU486 arrives in Italy
Harsh sentence Vatican
go-ahead by the majority of the drug
the marketing of the abortion pill
ROME - The RU486 arrives in Italy. After a meeting lasting more than four hours, arrived late Thursday in the go-ahead by a majority (four to one) by the Italian drug at the abortion pill. The Board of Directors AIFA has approved the marketing of the drug in our country already marketed in several other countries. The Board voted in favor of the AIFA President and pill Sergio Pecorelli advisers John Bissoni, Claudio De Vincenti, Gloria Saccani Jotti. To express themselves was rather negative Romano Colozzi, Councillor for Resources and Finance of the Lombardy Region. The RU486 can be used only in hospitals in Italy, as well as Law 194 provides for the voluntary interruption of pregnancy. In the provisions, said the commissioner Bissoni, there is a "point of maximum compliance with Law 194 and for use in hospitals. After a long investigation it was recommended to use the drug - he added - within the forty-ninth day, ie before the seventh week. " Within this period, in fact, complications for the use of the drug are similar to those of surgical abortion, the commissioner concluded.
THE ORDER OF THE VATICAN - Even before the AIFA had ruled, the Vatican had returned to the attack on the abortion pill. L'Osservatore Romano had addressed the crux of RU486 in the morning bringing the concerns expressed by the Welfare Undersecretary Eugenia Roccella. "The decision in favor of the AIFA marketing - according to the Secretary, it is not obvious, in light of the 29 deaths among women in various countries around the world caused by RU486. Safety of the pill, then, "still a lot of shadows, '" wrote the Vatican newspaper. It was then Monsignor Elio Sgreccia, president emeritus the Pontificia Academia pro Vita, to explain that the pill in question results in excommunication for women who make use of as well as for physicians who prescribe it because its intake is similar in all respects surgical abortion . "From the canonical point of view is like a surgical abortion" emphasizes the bishop. "The recruitment of RU486 is equivalent to a voluntary abortion with effect safe, because it does not work if the drug is required to proceed with surgical abortion. Nothing is missing. What's different is the morning-after pill, which, while aimed at stopping pregnancy does not intervene with certainty that there was after conception. For RU486, and then there is the excommunication of the physician, for women and for those that drive its use. " "I remain appalled by the attitude of AIFA (Italian Agency for Medicines)" Sgreccia and also said "I hope - he added - that there is an intervention by the government and relevant ministers" because the abortion pill RU486 is "not a drug, but a deadly poison. "
"aggravated RISK FOR THE MOTHER" - The Pill "has an abortifacient effect, then apply - Sgreccia continues - all the considerations that apply when it comes to abortion. There is also an aggravating factor that should give pause to even those who support the legalization surgical abortion, and the risk to the mother. More than twenty women died as a result of administration of the drug. This drug takes, therefore, the value of the poison. It is essentially a not-for-health, but at the end of death. It goes against the fundamental rule of life of the mother. It should, for this reason, suspend all. Furthermore - continued the bishop - you try to download the single woman the responsibility of the decision. We return to a form of privatization of abortion. At first it was just legalized abortion to remove it from hiding, now the doctor washes his hands and the weight falls on the woman of conscience. "
"SULL'AIFA Political and economic pressure "- then Sgreccia has no doubts about the causes which impel the AIFA the liberalization of the drug: it is, according to the bishop, of 'political and economic pressure."
July 30, 2009 (Last updated: July 31, 2009)
Corriere.it
ABORTION: FLOWER (FN), READY FOR INFORMATION CAMPAIGN ON RISK
RU486 (ASCA) - Roma, 30 July - In the event that received RU486 the go-ahead by AIFA''Forza Nuova prepares' an intense information campaign on the consequences of the product.'' This was announced by Roberto Fiore, Secretary of Forza Nuova.
''While the debate on the abortion pill is becoming more 'intense - continues Fiore - And increase day by day, against, which are now the majority of Italians, the big pharmaceutical companies become more compact in order to assert their huge economic interests on the skin of women and all citizens. The pill and 'dangerous to the health of women, as well as inaugurating a new frontier of the assassination casual. I hope that the Board of Directors of the Italian Drug Agency (AIFA) does not approve the legalization of the sale of RU486, although I fear cedars' the enormous pressure of the manufacturers.''
ROME - would be at least 29 deaths recorded among women following the use of the RU486 abortion pill, according to figures supplied by the manufacturer to the Ministry Exelgyn of Health, and then Italian Drug Agency (AIFA). This figure "it does not appear in the minutes of the Technical Committee of the European scientific AIFA or drugs EMEA." This was confirmed by the Undersecretary of Health, Eugenia Roccella, during the presentation of the report to Parliament on the implementation of Law 194 for the voluntary interruption of pregnancy. The data relating to deaths associated with the use of the pill RU486 in various countries had been circulating in recent weeks despite having been declassified by the company for reasons of privacy. Tomorrow, the Board
Italian Drug Agency (AIFA) will evaluate the marketing in Italy of the abortion pill RU486, but not the go-ahead is obvious: "The assessment of AIFA is not just a bureaucratic step." He said the Welfare Undersecretary Eugenia Roccella, during the drawing of the report to Parliament on the implementation of Law 194 on the voluntary interruption of pregnancy. "Tomorrow - said Roccella - the Board reviews the AIFA will be done and it is not a bureaucratic step, even if the green light by the Scientific Committee of AIFA is already a fundamental act." Referring then to the use of the RU486 pill in the context of regional protocols on the part of some health institutions, Roccella said on the value specified in the report to the Parliament and in 2007 under which "some institutions have used this pharmacological approach to the termination of pregnancy for a total of 1,010 cases, 0.8% of all terminations of pregnancy (VIP). "Currently, Roccella said, given that the process of authorization ' marketing in Italy is not yet complete, for this procedure, there are no systematic measurements abortion. Data from some regions, he added, "however, indicate a practice of treatment in day hospital, with a recommended use for this discrepancy drug by two different opinions of the Higher Health Council, under which abortion with RU486 should be completed within the hospital. "
All risks to be from those who produce
The news was leaked in late June, a detailed dossier on the abortion pill was sent to the Ministry of Health by the manufacturer of RU486, the French Exelgyn, and this "shot" for competence Italian Agency the drug (AIFA) for technical and scientific evaluation.
And from what had been revealed by some news agencies in the dossier for the first time they admitted 29 people died from the use of abortion pill, although not in all cases the use of the drug was intended termination of pregnancy but also for a "compassionate use". The opening still wider doubts about the decision of the board of AIFA. In fact, the greatest possible transparency in evaluation of the data had been invoked by the Undersecretary of Health Eugenia Roccella, to meet with criteria of scientific objectivity to the doubts that continue to raise the abortion pill. But apparently this in the end was not done.
action of RU486, events and was among the most frequent demand to speak to the news of the deaths and adverse events should be published and analyzed for an assessment as objective as possible of the drug. Especially after an editorial in the New England Journal of Medicine four years ago had revealed that despite the difference of absolute numbers, the mortality rate after an abortion doctor (or chemical) is ten times more higher than that for surgical abortion, in spite of the "fairy tale" would have us believe that modern and easier to use the drug for the termination of pregnancy.
The case of the producer, while not assuming any direct link between the consumption of RU486 and deaths indicates that it is not just 16 (or 17 as reported to occur in the last few months) cases of death from the use of mifepristone, but 29 in the period between December 28, 1988 and February 28, 2009. To whom should be added only two deaths after taking the second drug (misoprostol) which is essential to the completion of the abortion procedure, but that the manufacturer has never indicated to use abortion.
not only dead, however, emerge from the adverse effects. The most serious case - published in "Obstetrics and Gynecology" - is for a woman who, after a chemical abortion with RU486, is met with Streptococcus infection which made it necessary to amputate the leg below the knee. Moreover many of the deaths were attributed to the action of a rare bacterium (Clostridium sordellii), which is presented to an extraordinary degree frequent after use of mifepristone.
should note that, for his work on hormones, mifepristone has long been indicated for the treatment of Cushing's disease, and was also experienced (as evidenced scientific publications) in antidepressant therapy. And that the second drug, misoprostol, an ulcer is: the same manufacturer has not recommended for use around the world and abortion in Italy should be used "off label."
http://www.avvenire.it/Cronaca/ru+rischi_200907310940103200000.htm
http://www.tradizione.biz/forum/viewtopic.php?p=180919 # 180919
0 comments:
Post a Comment